We have investigated the prevalence of HPV 16. using polymerase chain reaction (PCR). in Spanish women from the Basque region who had normal cervical cytology. We have correlated this with DNA adduct levels in the cervix. Both the DNA adduct assay and the HPV assay were carried out on exfoliated cervical cells recovered from cervical scrapes. after the preparation of a routine Papanicolaou smear.
Numerous epidemiological studies have shown that smoking is a risk factor for cervical cancer (Winkelstein, 1990) . Molecular research has recently demonstrated that the presence of smoking-related DNA adducts (chemical carcinogens that exert their biological activity through covalent modification of DNA) is significantly higher in the cervical DNA of smokers than non-smokers (Simons et al.. 1993) . This suggests that smoking may play a causal role in the development of cervical cancer.
Human papillomavirus 16 (HPV 16) is a known oncogenic virus (Dyson et al.. 1989 : Werness et al.. 1990 ) which is present in the female genital tract. There is evidence that the virus may contribute to the genesis of cervical cancer and cervical intraepithelial neoplasia (Van Den Brule et al.. 1991; Schiffman et al.. 1993) . It has been suggested that HPV may act synergistically with tobacco products (Zur Hausen, 1982) or that tobacco products may allow penetrance of HPV by causing local immunosuppression within the cervix (Barton et al., 1988) .
The Basque region of Spain is known to have a low incidence of cervical cancer (Mugica van Herckenrode et al.. 1992) , whereas the prevalence of HPV (using slot-blot hybridisation) in the cervices of these Spanish women has previously been demonstrated to be similar to that found in countries with a high incidence rate of cervical cancer (Mugica van Herckenrode et al., 1992) . This supports the case for HPV 16 acting synergistically with some other agent.
We have investigated the prevalence of HPV 16. using polymerase chain reaction (PCR). in Spanish women from the Basque region who had normal cervical cytology. We have correlated this with DNA adduct levels in the cervix. Both the DNA adduct assay and the HPV assay were carried out on exfoliated cervical cells recovered from cervical scrapes. after the preparation of a routine Papanicolaou smear.
Materials and methods
Subjects and samples Thirty-eight Spanish women who live in the Basque region of Spain were recruited into the study. All were undergoing a routine cervical smear test at a gynaecology clinic.
The cervical scrape was taken by an experienced gynaecologist using an Ayre spatula. The cells from the spatula were spread on a slide, which was then fixed with alcohol. The spatula was broken off into 10 ml of phosphatebuffered saline and stored at -20'C until DNA extraction.
All women answered a questionnaire on their smoking habit. They were asked whether they had ever (currently or previously) smoked. (Gupta. 1985) . Butanol phase residues were 3'P post-labelled (Gupta et al.. 1982 : Phillips et al.. 1988 (90 to D2): D4. 1.7 M sodium phosphate, pH 6 (onto filter paper wick, same direction as D3). Detection of radioactive material on the chromatograms (after removal of origin area) was by autoradiography at -75°C. The areas of the chromatograms containing the radioactive material were excised and assayed for radioactivity by Cerenkov counting, while an area not containing significant radioactivity was also excised and counted to provide a background level. The extent of DNA modification was calculated from the levels of radioactivity on the relevant areas of the chromatograms and the specific activity of the [a-32P]ATP (Reddy and Randerath, 1986 analysis by 3P post-labelling. Five samples (13.2%). two from smokers and three from non-smokers. contained insufficient DNA to undergo 3-P post-labelling. The chromatograms of the 33 adequate samples revealed a diagnonal zone of radioactivity (see Figure 1) . This is indicative of bulky aromatic DNA adducts and similar to that seen in previous human cervical samples (Cuzick et al.. 1990 : Phillips et al.. 1990 : Simons et al.. 1993 ). The range of adduct levels was from 2.89 to 16.17 adducts 10' nucleotides (see Figure   2 ). The median DNA adduct level of the smokers was 8.55 adducts 10' nucleotides (95% CI 6.55-9.97) compared with 4.94 adducts 10' nucleotides (95% CI 4.18-5.88) of nonsmokers. Self-reported smokers had significantly higher DNA adduct levels than non-smokers (P = 0.002) (see Figure 2) . Method of analysis Women were designated smokers or non-smokers on the basis of self-reported smoking habit. The DNA adduct levels of women who smoked were compared with the DNA adduct levels of non-smokers. In addition to the DNA adducts, the HPV status of each specimen was also compared between smokers and non-smokers.
Statistical calculations
The non-parametric Mann-Whitney L-test was applied.
Results
All smears taken from the 38 women enrolled into the study were suitable for cytological analysis. Thirty-three women had normal cervical smears. Four had inflammatory atypia and one had normal cytology associated with changes consis- 16-negative smokers or beteween HPV 1 6-positive nonsmokers and HPV 16-negative non-smokers (see Table I ).
Diauio
Covalent modification of DNA to form DNA adducts is a critical early step in chemical carcinogenesis (Hoffman and Hecht, 1990) , and therefore detection of DNA adducts provides evidence of exposure of the cervix to carcinogens.
The demonstration in this study of significantly higher DNA adduct levels in smokers as compared with nonsmokers is consistent with previous work on cervical tissue (Simons et al., 1993) . This provides further molecular evidence of smoking-related carcinogenic agents affecting the DNA of the cervical epithelium.
The chromatograms of the samples revealed a diagonal zone of radioactivity which was similar to that observed in previous studies (Cuzick et al., 1990; Simons et al., 1993) using cervical biopsy material. This study is unique as we have demonstrated DNA adducts using DNA extracted from exfoliative cervical cells. This confirms the hypothesis of our pilot study (Phillips et al., 1990) .
The HPV 16-positive rate (using PCR) of 42% was very similar to that found previously (Bloomfield, 1991 The Basque region of Spain was chosen because a large proportion of the women in this region smoke and the incidence of HPV infectivity has previously been shown to be similar to other countries (Mugica van Herckenrode et al., 1992) . We intend to extend this pilot study and continue long-term follow-up to see if these additional tests can assist in predicting which women are at greater risk of eventually developing cervical cancer.
